06. February 2012
Benchtop Bioreactors - Causing a Stir
As the market for biologics continues to grow, advanced benchtop bioreactors can change the way biomanufacturers standardise and streamline process development. Dr. Kathrin Schmale and Dr. Karl Rix at DASGIP discuss the factors to consider when selecting a bioreactor in the latest issue of European Biopharmaceutical Review (EBR).